| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |